Browse the evidence

Greater improvement in blood sugar control was associated with better cognitive scores.

Improving blood sugar control may enhance cognitive function in older adults with diabetes.

Eccentric duration was significantly and inversely correlated with average concentric velocity (ACV) at 60% (r = −0.408, p = 0.004) and 80% (r = −0.477, p = 0.001) of 1RM squat.

Practitioners should consider the duration of the eccentric phase to optimize concentric performance.

The leg-to-leg BIA system provides a valid measure of body composition change in overweight premenopausal women during a 32-week community-based weight loss program.

Practitioners can use the leg-to-leg BIA system to effectively monitor body composition changes in similar populations.

GLP-1 receptor agonists (GLP-1 RAs) may improve obstructive sleep apnea (OSA) symptoms by reducing fat deposition around the upper airway and decreasing systemic inflammation.

Practitioners may consider GLP-1 RAs as a potential treatment option for improving OSA symptoms in obese patients.

GLP-1 RAs may enhance traditional OSA treatments, offering an integrated approach targeting the root cause of obesity in OSA.

Practitioners should consider integrating GLP-1 RAs into OSA management strategies.

GLP-1 RAs may provide benefits for other obesity-related comorbidities, including hypertension and cardiovascular disease.

Practitioners should be aware of the potential for GLP-1 RAs to address comorbidities in obese OSA patients.

Semaglutide reduced HbA1c by 0.46% of total hemoglobin in SGA-treated patients with schizophrenia, prediabetes, and obesity.

Semaglutide may be an effective treatment option for managing blood glucose levels in this patient population.

Semaglutide improved physical quality of life by 3.75 points on the SF-36v2.

Semaglutide may enhance physical quality of life for patients in this group.

GLP-1RA users had a lower risk of stroke (HR, 0.81; 95% CI, 0.70-0.93) compared to other antidiabetic drug users.

Practitioners may consider GLP-1RAs as a treatment option for reducing stroke risk in this population.

GLP-1RA users had a lower risk of all-cause mortality (HR, 0.70; 95% CI, 0.63-0.78) compared to other antidiabetic drug users.

Practitioners may consider GLP-1RAs as a treatment option for reducing all-cause mortality in this population.

High school students in Philadelphia experienced reductions in soda consumption due to sugar-sweetened beverage taxes.

Implementing sugar-sweetened beverage taxes may effectively reduce soda consumption among adolescents.

Average body mass index (BMI) among high school students decreased in Philadelphia, San Francisco, and Oakland following the implementation of sugar-sweetened beverage taxes.

Sugar-sweetened beverage taxes may contribute to lower BMI in adolescents.

Weight loss interventions in women with breast cancer significantly reduced body weight and fat mass but also reduced lean mass.

Practitioners should be aware that while weight loss interventions can be effective, they may also lead to reductions in lean mass.

ATP supplementation has been reported to result in positive effects on muscle mass, strength, and power gains.

ATP supplementation may be beneficial for enhancing muscle performance metrics.

Obesity is a leading risk factor for cardiovascular disease (CVD).

Clinicians should prioritize addressing obesity to mitigate CVD risks.

Obesity contributes to the emergence of cardiovascular risk factors such as dyslipidaemia, type 2 diabetes, hypertension, and sleep disorders.

Addressing obesity may help in managing these associated cardiovascular risk factors.

Some researchers claim that the timing of nutritional consumption may be more critical to muscle development than the absolute daily consumption of nutrients.

Practitioners should consider the potential importance of nutrient timing in relation to total daily intake for muscle development.

Semaglutide and tirzepatide show therapeutic potential as cardioprotective and nephroprotective agents.

Practitioners can consider semaglutide and tirzepatide for patients at risk of cardiovascular and renal diseases.

The GLP-1RA/GIPR antagonist MariTide achieved substantial reductions in weight and HbA1c.

MariTide may be an effective option for weight management and glycemic control in patients.

Women who were obese at both 20 years old and currently, as well as those who became obese, have a similar high risk of non-communicable diseases (NCDs).

Practitioners should be aware that both persistent and newly obese women are at high risk for NCDs.

Leisure time physical activity attenuates the negative effects of obesity on non-communicable diseases, particularly for consistently obese women.

Encouraging physical activity can help mitigate health risks associated with obesity.

The prevalence of non-communicable diseases among women who were no longer obese is similar to that of consistently non-obese women.

Weight loss may lead to similar health outcomes as never being obese.

A national 10% tax on sugar-sweetened beverages and processed meats would prevent a total of 33,700 CMD deaths/year.

Implementing a 10% tax on unhealthy foods could significantly reduce CMD mortality.

A SNAP-targeted 30% subsidy for healthy foods would offer the largest reductions in CMD mortality and disparities.

Targeted subsidies for healthy foods could greatly reduce CMD mortality and health disparities.